Nicholas Keen Bicycle Therapeutics PLC (BCYC) insider trading activity

BCYC Quotes by TradingView

Nicholas Keen is CHIEF SCIENTIFIC OFFICER of BICYCLE THERAPEUTICS plc. Currently has a direct ownership of 62,024 shares of BCYC, which is worth approximately $1.49 Million. The most recent transaction as insider was on Jul 03, 2024, when has been sold 779 shares (Ordinary Shares) at a price of $19.64 per share, resulting in proceeds of $15,299. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62K
0% 3M change
62.23% 12M change
Total Value Held $1.49 Million

Nicholas Keen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 03 2024
SELL
Open market or private sale
$15,299 $19.64 p/Share
779 Reduced 1.24%
62,024 Ordinary Shares
Apr 03 2024
SELL
Open market or private sale
$18,809 $23.81 p/Share
790 Reduced 1.24%
62,803 Ordinary Shares
Jan 03 2024
SELL
Open market or private sale
$46,200 $17.5 p/Share
2,640 Reduced 3.99%
63,593 Ordinary Shares
Jan 02 2024
BUY
Grant, award, or other acquisition
-
28,000 Added 29.71%
66,233 Ordinary Shares
Oct 03 2023
SELL
Open market or private sale
$5,440 $20.0 p/Share
272 Reduced 0.71%
38,233 Ordinary Shares
Jul 03 2023
SELL
Open market or private sale
$8,433 $25.1 p/Share
336 Reduced 0.87%
38,505 Ordinary Shares
Apr 03 2023
SELL
Open market or private sale
$6,734 $21.11 p/Share
319 Reduced 0.81%
38,841 Ordinary Shares
Jan 03 2023
SELL
Open market or private sale
$52,802 $29.06 p/Share
1,817 Reduced 4.43%
39,160 Ordinary Shares
Jan 03 2023
BUY
Grant, award, or other acquisition
-
17,500 Added 29.93%
40,977 Ordinary Shares
Jan 03 2022
BUY
Grant, award, or other acquisition
-
15,000 Added 38.98%
23,477 Ordinary Shares
Dec 21 2021
BUY
Exercise of conversion of derivative security
$216,678 $14.0 p/Share
15,477 Added 50.0%
15,477 Ordinary Shares
Oct 05 2021
SELL
Open market or private sale
$98,228 $45.1 p/Share
2,178 Reduced 100.0%
0 Ordinary Shares
Oct 01 2021
SELL
Open market or private sale
$53,460 $45.0 p/Share
1,188 Reduced 35.29%
2,178 Ordinary Shares
Sep 16 2021
SELL
Open market or private sale
$87,995 $45.01 p/Share
1,955 Reduced 36.74%
3,366 Ordinary Shares
Sep 15 2021
SELL
Open market or private sale
$135,000 $45.0 p/Share
3,000 Reduced 36.05%
5,321 Ordinary Shares
Sep 02 2021
SELL
Open market or private sale
$400,000 $40.0 p/Share
10,000 Reduced 54.58%
8,321 Ordinary Shares
Jul 14 2021
SELL
Open market or private sale
$350,000 $35.0 p/Share
10,000 Reduced 35.31%
18,321 Ordinary Shares
Mar 31 2021
SELL
Open market or private sale
$300,000 $30.0 p/Share
10,000 Reduced 26.1%
28,321 Ordinary Shares
Mar 15 2021
SELL
Open market or private sale
$6,076 $28.0 p/Share
217 Reduced 0.56%
38,321 Ordinary Shares
Mar 12 2021
SELL
Open market or private sale
$281,163 $28.74 p/Share
9,783 Reduced 20.25%
38,538 Ordinary Shares
NK

Nicholas Keen

CHIEF SCIENTIFIC OFFICER
Cambridge, X0

Track Institutional and Insider Activities on BCYC

Follow BICYCLE THERAPEUTICS plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCYC shares.

Notify only if

Insider Trading

Get notified when an Bicycle Therapeutics PLC insider buys or sells BCYC shares.

Notify only if

News

Receive news related to BICYCLE THERAPEUTICS plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCYC